Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Avian flu study offers new insights
Flock of chickens
Researchers analysed the specific properties that enable some strains of H9N2 to adapt for successful human infection.
Scientists analyse properties that enable some strains to infect humans

How the most common type of avian influenza virus, H9N2, is able to infect humans has been identified by researchers at the Pirbright Institute.

While considered less pathogenic than some forms of avian flu virus, H9N2 viruses still cause significant losses for the poultry industry in many countries - particularly Asia, the Middle East and North Africa.

In Hong Kong, China, Bangladesh and Egypt the number of human infections of H9N2 has been on the rise. Although these infections have been mild, concerns increased when tests revealed its potential for human-to-human airborne transmission - a property normally associated with the potential to cause pandemic.

In a study, published in Nature’s Emerging Microbes & Infections, researchers analysed the specific properties that enable some strains of H9N2 to adapt for successful human infection. They found that bird flu strains can infect humans when a mutation occurs that enables a preference for binding receptors that are ‘human-like’.

The researchers also assessed how the stability of H9N2 haemagglutinins affects the PH of fusion. To infect humans, the haemagglutinin must be stable enough to survive in respiratory droplets for airborne transmission.

The H9N2 strains were found to possess haemagglutinins which were stable at lower pH levels - something which was mirrored in other bird flu strains which have adapted to infect humans in the past. The team established that the stability at a lower pH was a more important factor for virus fusion than the preference for binding to different receptors.

“Based on the two properties we tested, our results indicate that the lineages with the highest zoonotic potential may be those currently circulating in southern China and Vietnam (G1 ‘Eastern’ sub-lineage),” commented Dr Munir Iqbal, lead author of the study.

“However, evaluations in this study of the lineages prevalent in China and Vietnam (BJ94) and from Bangladesh to Morocco (‘Western’ G1 sub-lineage), suggest these viruses could also adapt to humans with relatively few additional mutations and merit further research.”

“This study has provided us with some important new insights which are helping us develop our understanding of these influenza viruses from molecular, biophysical and virological perspectives. We hope this will inform risk assessments of their zoonotic and pandemic potential and help improve global vaccine strategies”.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.